By David E. Coit, Jr., DBA, CM&AA
Volume 3 Issue 23, November 9, 2016
This past week, I listened to a compelling presentation on the evolving nature of value in healthcare by Monica Oss of Open Minds. At the conclusion, she noted that value-based payments for healthcare services and products "are at the core of healthcare innovation" and that "providers must be able to demonstrate value internally and externally."
The financial value of a healthcare company is obviously based on its bottom line. However, great financial results mean little if other people, especially investors or potential purchasers of the business, aren't confident that they represent reality.
As the book Financial Intelligence points out, the perceived value of a company is tied up in "the art of using limited data to come as close as possible to an accurate description of how well a company is performing." Without that accuracy, potential investors are likely to have nagging questions and doubts.
Here are four reasons why the quality of your financials is so important:
1. For most businesses financials are the first thing potential buyers look at after a thumbnail outline of the nature of the business and whether or not it is a going concern. If your results are poor that is one matter, but often the bigger issue is whether or not the results make sense from the financials that are presented.
2. Your financials are part of the trust that should evolve between seller and investor. If there is clarity, trust can develop even if there are some challenges. If there are myriad difficult-to-decipher add backs that create remarkably positive results, distrust is usually the result.
3. In our experience, the quality of financials is a projection of the business personality of the owner, which reflects the larger culture of the business enterprise. How attentive is the owner to the daily needs of the business, including employees and customers?
4. The quality of the financials is often correlated with how active management and employees are in the operational accountability of the business. The clarity of the financials is especially important for businesses that are not too dependent on the owner and are relatively transparent.
Buyers, customers, and funders don't expect perfection. If they are successful themselves, they understand the challenges that impact every healthcare business. They do, however, expect to be able to understand the operational truths of your company, which is why the quality of your financials is very big deal.
David is a seasoned commercial and corporate finance professional with over 30 years’ experience. As part of the VERTESS team, he provides clients with valuation, financial analysis, and consulting support. He has completed over 150 business valuations. Most of the valuation work he does at VERTESS is for healthcare companies such as behavioral healthcare, home healthcare, hospice care, substance use disorder treatment providers, physical therapy, physician practices, durable medical equipment companies, outpatient surgical centers, dental offices, and home sleep testing providers.
David holds certifications as a Certified Valuation Analyst (CVA), issued by the National Association of Certified Valuators and Analysts, Certified Value Growth Advisor (CVGA), issued by Corporate Value Metrics, Certified Merger & Acquisition Advisor (CM&AA), issued by the Alliance of Merger & Acquisition Advisors, and Certified Business Exit Consultant (CBEC), issued by Pinnacle Equity Solutions. Moreover, the topic of his doctoral dissertation was business valuation.
David earned a Doctorate in Business Administration from Walden University with a specialization in Corporate Finance (4.0 GPA), an MBA from Keller Graduate School of Management, and a BS in Economics from Northern Illinois University. He is a member of the Golden Key International Honor Society and Delta Mu Delta Honor Society.
Before joining Vertess, David spent approximately 20 years in commercial finance, having worked in senior-level management positions at two Fortune 500 companies. During his commercial finance career, he analyzed the financial condition of thousands of companies and had successfully sold over $2 billion in corporate debt to institutional buyers.
He is a former adjunct professor with 15 years' experience teaching corporate finance, securities analysis, business economics, and business planning to MBA candidates at two nationally recognized universities.